These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15198514)

  • 1. Amphiphilic star-like macromolecules as novel carriers for topical delivery of nonsteroidal anti-inflammatory drugs.
    Djordjevic J; Michniak B; Uhrich KE
    AAPS PharmSci; 2003 Oct; 5(4):E26. PubMed ID: 15198514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of original bioactive formulations based on sugar-surfactant/non-steroidal anti-inflammatory catanionic self-assemblies: a new way of dermal drug delivery.
    Consola S; Blanzat M; Perez E; Garrigues JC; Bordat P; Rico-Lattes I
    Chemistry; 2007; 13(11):3039-47. PubMed ID: 17285653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro topical delivery of non-steroidal anti-inflammatory drugs through human skin.
    Vincent CM; Laugel C; Marty JP
    Arzneimittelforschung; 1999 Jun; 49(6):509-13. PubMed ID: 10417867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microemulsion: a novel transdermal delivery system to facilitate skin penetration of indomethacin.
    Chen L; Tan F; Wang J; Liu F
    Pharmazie; 2012 Apr; 67(4):319-23. PubMed ID: 22570938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly n-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: in vitro release and in vivo skin penetration.
    Miyazaki S; Takahashi A; Kubo W; Bachynsky J; Löebenberg R
    J Pharm Pharm Sci; 2003; 6(2):238-45. PubMed ID: 12935436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal delivery of ketoprofen: the influence of drug-dioleylphosphatidylcholine interactions.
    Garcia MT; da Silva CH; de Oliveira DC; Braga EC; Thomazini JA; Bentley MV
    Pharm Res; 2006 Aug; 23(8):1776-85. PubMed ID: 16858649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced skin permeation using polyarginine modified nanostructured lipid carriers.
    Shah PP; Desai PR; Channer D; Singh M
    J Control Release; 2012 Aug; 161(3):735-45. PubMed ID: 22617521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced transdermal delivery of ketoprofen from bioadhesive gels.
    Singh S; Gajra B; Rawat M; Muthu MS
    Pak J Pharm Sci; 2009 Apr; 22(2):193-8. PubMed ID: 19339232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of an Inflammation-Sensitive Polyelectrolyte-Based Topical Drug Delivery System for Arthritis.
    Bijukumar D; Choonara YE; Murugan K; Choonara BF; Kumar P; du Toit LC; Pillay V
    AAPS PharmSciTech; 2016 Oct; 17(5):1075-85. PubMed ID: 26515798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy and skin permeability of topical NSAID preparations used in Europe.
    Komatsu T; Sakurada T
    Eur J Pharm Sci; 2012 Dec; 47(5):890-5. PubMed ID: 22985876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occlusion effect on transcutaneous NSAID delivery from conventional and carrier-based formulations.
    Cevc G; Mazgareanu S; Rother M; Vierl U
    Int J Pharm; 2008 Jul; 359(1-2):190-7. PubMed ID: 18499370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved percutaneous delivery of ketoprofen using combined application of nanocarriers and silicon microneedles.
    Vučen SR; Vuleta G; Crean AM; Moore AC; Ignjatović N; Uskoković D
    J Pharm Pharmacol; 2013 Oct; 65(10):1451-62. PubMed ID: 24028612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability.
    Paolino D; Ventura CA; Nisticò S; Puglisi G; Fresta M
    Int J Pharm; 2002 Sep; 244(1-2):21-31. PubMed ID: 12204562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microemulsion-Based Topical Hydrogels of Tenoxicam for Treatment of Arthritis.
    Goindi S; Narula M; Kalra A
    AAPS PharmSciTech; 2016 Jun; 17(3):597-606. PubMed ID: 26285672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of formulation variables on the percutaneous permeation of ketoprofen from gel formulations.
    El-Kattan AF; Asbill CS; Kim N; Michniak BB
    Drug Deliv; 2000; 7(3):147-53. PubMed ID: 10989915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of percutaneous permeation of flurbiprofen and ketoprofen after application of transdermal patches using a lateral sectioning approach in hairless rats.
    Goi N; Morishita K; Taniguchi A; Ishii T; Saitoh K
    Pharm Dev Technol; 2010 Dec; 15(6):658-65. PubMed ID: 20883157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of skin permeability for three diclofenac topical formulations: an in vitro study.
    Folzer E; Gonzalez D; Singh R; Derendorf H
    Pharmazie; 2014 Jan; 69(1):27-31. PubMed ID: 24601219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of permeation enhancers on the release of ketoprofen through transdermal drug delivery systems.
    Singh SK; Durrani MJ; Reddy IK; Khan MA
    Pharmazie; 1996 Oct; 51(10):741-4. PubMed ID: 8941942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation development, in vitro and in vivo evaluation of microemulsion-based gel loaded with ketoprofen.
    Nikumbh KV; Sevankar SG; Patil MP
    Drug Deliv; 2015; 22(4):509-15. PubMed ID: 24266589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterisation of novel analgesic product based on self-regulating drug carriers.
    Cevc G; Vierl U; Mazgareanu S
    Int J Pharm; 2008 Aug; 360(1-2):18-28. PubMed ID: 18524509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.